Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk ...

Find out how you can make money be losing weight with HeathlyWage. Get the details on how it works, who can apply, how much ...

Then I actually saw an ad on Instagram for the app, and after I did that, I took off," he added. The 'must-have' £30 wearable ...

LONDON/COPENHAGEN, Dec 23 (Reuters) - Novo Nordisk secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ground lost ‌to rival Eli Lilly. Booming ...

New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits.

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Weight loss company Noom will now be available to employers to purchase directly through Castlight Health's healthcare navigation platform. "From our standpoint, you can have the greatest products in ...

Castlight's personalized health benefits platform provides seamless access to Noom's health programs including diabetes, GLP-1s and weight support for employers and health plans. Castlight Health ...

Noom is a digital health platform that focuses on building sustainable habits for long-term wellness. The program uses a psychology-based approach and a color-coding system to help users understand ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...